As of January 22, 2025, Fulgent Genetics (FLGT) has a market cap of $0.52 billion USD. According to our data, Fulgent Genetics is ranked No.6061 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.52 B |
-7.96%
|
Dec 31, 2024 | $0.56 B |
-36.11%
|
Dec 29, 2023 | $0.88 B |
-2.92%
|
Dec 30, 2022 | $0.91 B |
-70.39%
|
Dec 31, 2021 | $3.08 B |
93.07%
|
Dec 31, 2020 | $1.59 B |
303.88%
|
Dec 31, 2019 | $0.39 B |
306.94%
|
Dec 31, 2018 | $96.96 M |
-27.63%
|
Dec 29, 2017 | $0.13 B |
-62.14%
|
Dec 30, 2016 | $0.35 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Pacific Biosciences
PACB
|
$0.52 B |
0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.73 B |
0.006 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Market Cap | = | FLGT Stock Price | * | FLGT Shares Outstanding |
= | $17.00 | * | 30.59 M | |
= | $0.52 B |